1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
Advances in Monoclonal Antibody Therapeutics 

Advances in Monoclonal Antibody Therapeutics 

  • September 2015
  • 94 pages
  • ID: 3312068

Summary

Table of Contents

Advances in monoclonal antibody therapeutics

Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets, is playing a crucial role in the pharmaceutical industry. This trend shows the strong focus of top biopharmaceutical companies in biologics, including monoclonal antibody therapeutics. This research service discusses the emerging trends in monoclonal antibody therapeutics on a global scale, through a detailed strategic assessment of the industry environment.

Key Findings

Next-generation products are expected to be superior to first-generation products, in terms of potency against disease targets, ability to treat more than one aspect of a disease simultaneously, better and cheaper production processes and fewer side effects.

Big Pharma companies (Amgen, Novartis, Pfizer, Roche), are advancing through deals with potentially very large payoffs to acquire antibody technologies, compensating some patent losses in more traditional molecules and making easier to afford the advent of biosimilars.

Nanobodies (Ablynx), stapled peptides (Aileron), single-gene mutation gene therapy (BlueBird Bio), neurotrophic factor gene therapy (Sangamo BioSciences), Dicer-substrate short interfering RNAs (Dicerna), therapeutic vaccines (Galena), dual-affinity re-targeting (MacroGenics), bispecific T-cell engaging antibodies (Amgen), locked nucleic acids (Roche), and XmAbs (Xencor), are highlighted.

Although immuno-modulatory antibodies have also recently achieved remarkable clinical success, regulatory issues in biologics plays a crucial role in the development of monoclonal antibody therapeutics.

A profound knowledge of the molecular basis of the disease, as well as, outstanding protein-engineering techniques, mechanisms of action and resistance, including the behavior exhibited by the immune system and the targeted cells is essential. In terms of therapeutic areas, the use of monoclonal antibodies in immuno-oncology has achieved considerable success in recent years. Antibody–drug conjugates are powerful new treatment options for lymphomas and solid tumors. Principal deals are strongly correlated to immuno-oncology areas.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global R&D Outsourcing Services Market 2017-2021

R&D Outsourcing Services Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • November 2017
  • by Infiniti Research Limited

About R&D Outsourcing ServicesR&D outsourcing refers to outsourcing non-physical engineering R&D tasks such as designing, simulation, and consultation to specialized vendors. It involves factors such as ...

Research and Development in Germany: ISIC 73

Germany: Research and Development analysis

  • $ 657
  • Industry report
  • October 2017
  • by Euromonitor International

Euromonitor International’s Industrial reports provide a 360 degree view of an industry.The Industrial market report offers a comprehensive guide to the size and shape of the Research and Development ...

Research and Development in Italy: ISIC 73

Italy: Research and Development report

  • $ 657
  • Industry report
  • December 2017
  • by Euromonitor International

Euromonitor International’s Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Research and Development ...


ref:plp2015

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.